Indigenous Healthcare Tech Innovations Transferred to Industry

Two indigenous healthcare technologies developed under MeitY's NNetRA project were transferred to industry at an IIT Delhi event. The technologies aim to detect prostate cancer and pathogens quickly. The transfer highlights India's strides in technological innovation and industry collaboration for sustainable development.

Two groundbreaking indigenous healthcare technologies, developed under the Ministry of Electronics and Information Technology (MeitY)-funded Nanoelectronics Network for Research and Applications (NNetRA) project, were officially transferred to industry on Wednesday. The transfer event was hosted by the Indian Institute of Technology (IIT) Delhi on July 31.

The first technology, known as "DNA Aptamer for Prostate Cancer Detection," was handed over to Dr. Swapnil Sinha of HUMMSA Biotech Pvt. Ltd. in Kolkata. Developed by Prof. Prashant Mishra and his team from IIT Delhi, this technology offers targeted binding to specific oncogenes, potentially serving as a theranostic tool for prostate cancer. Concurrently, the second technology, the "Photonic Chip-based Spectrometric Biosensor" for pathogen detection, was transferred to Mr. Nitin Zaveri of UNINO Healthcare Private Limited in Mumbai.

This revolutionary biosensor, developed by Prof. Joby Joseph and his team, allows for rapid and precise pathogen detection, aiding in the prevention and control of infectious diseases. Speaking at the event, MeitY Secretary S. Krishnan lauded the successful transfer and emphasized the importance of continued innovation, collaboration, and sustainable development in technology transfer. Distinguished dignitaries, including Professor Rangan Banerjee, Director of IITD, and other senior officials from MeitY, were present to witness the ceremony, marking a pivotal moment facilitated by IIT Delhi's Foundation for Innovation and Technology Transfer (FITT).

(With inputs from agencies.)